Arginase 1 Insufficiency Precipitates Amyloid-β Deposition and Hastens Behavioral Impairment in a Mouse Model of Amyloidosis
Authors:
Open Access
- 14 January 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11
Abstract
Alzheimer’s disease (AD) includes several hallmarks comprised of amyloid-β (Aβ) deposition, tau neuropathology, inflammation, and memory impairment. Brain metabolism becomes uncoupled due to aging and other AD risk factors, which ultimately lead to impaired protein clearance and aggregation. Increasing evidence indicates a role of arginine metabolism in AD, where arginases are key enzymes in neurons and glia capable of depleting arginine and producing ornithine and polyamines. However, currently, it remains unknown if the reduction of arginase 1 (Arg1) in myeloid cell impacts amyloidosis. Herein, we produced haploinsufficiency of Arg1 by the hemizygous deletion in myeloid cells using Arg1fl/fl and LysMcreTg/+ mice crossed with APP Tg2576 mice. Our data indicated that Arg1 haploinsufficiency promoted Aβ deposition, exacerbated some behavioral impairment, and decreased components of Ragulator-Rag complex involved in mechanistic target of rapamycin complex 1 (mTORC1) signaling and autophagy. Additionally, Arg1 repression and arginine supplementation both impaired microglial phagocytosis in vitro. These data suggest that proper function of Arg1 and arginine metabolism in myeloid cells remains essential to restrict amyloidosis.Keywords
This publication has 77 references indexed in Scilit:
- Metabolic profiling of Alzheimer's disease brainsScientific Reports, 2013
- Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using MetabolomicsPLOS ONE, 2013
- Wild-type microglia arrest pathology in a mouse model of Rett syndromeNature, 2012
- Clearance of Amyloid-β Peptides By Microglia and Macrophages: the Issue of What, When and WhereFuture Neurology, 2012
- Microglial alterations in human Alzheimer's disease following Aβ42 immunizationNeuropathology and Applied Neurobiology, 2011
- Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonismProceedings of the National Academy of Sciences, 2011
- Trafficking CD11b-Positive Blood Cells Deliver Therapeutic Genes to the Brain of Amyloid-Depositing Transgenic MiceJournal of Neuroscience, 2010
- Attenuation of AD‐like neuropathology by harnessing peripheral immune cells: local elevation of IL‐10 and MMP‐9Journal of Neurochemistry, 2009
- Recent advances in arginine metabolism: roles and regulation of the arginasesBritish Journal of Pharmacology, 2009
- Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogensNature Immunology, 2008